

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | basement membrane organization (GO:0071711) | 7.23719464 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.94373574 |
| 3 | synaptic vesicle maturation (GO:0016188) | 6.90558787 |
| 4 | enteric nervous system development (GO:0048484) | 5.97810814 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.96362862 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.68672483 |
| 7 | protein retention in ER lumen (GO:0006621) | 5.63530751 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.43242029 |
| 9 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.25382333 |
| 10 | vocalization behavior (GO:0071625) | 5.19281569 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.17786390 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.14965385 |
| 13 | glutamate secretion (GO:0014047) | 5.13948698 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 5.06218438 |
| 15 | developmental pigmentation (GO:0048066) | 5.02902928 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.96921895 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.93142951 |
| 18 | pigment cell differentiation (GO:0050931) | 4.86241105 |
| 19 | layer formation in cerebral cortex (GO:0021819) | 4.83438746 |
| 20 | melanocyte differentiation (GO:0030318) | 4.80477247 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.62371691 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 4.61388027 |
| 23 | proline transport (GO:0015824) | 4.61190780 |
| 24 | protein localization to synapse (GO:0035418) | 4.58358692 |
| 25 | amyloid precursor protein catabolic process (GO:0042987) | 4.54881077 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.53232727 |
| 27 | tyrosine metabolic process (GO:0006570) | 4.52634404 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 4.49798415 |
| 29 | exploration behavior (GO:0035640) | 4.44294957 |
| 30 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.43469780 |
| 31 | phenol-containing compound biosynthetic process (GO:0046189) | 4.29937436 |
| 32 | COPI coating of Golgi vesicle (GO:0048205) | 4.29459949 |
| 33 | Golgi transport vesicle coating (GO:0048200) | 4.29459949 |
| 34 | * response to dietary excess (GO:0002021) | 4.27499802 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 4.15852037 |
| 36 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.15308297 |
| 37 | glycine transport (GO:0015816) | 4.14152480 |
| 38 | gamma-aminobutyric acid transport (GO:0015812) | 4.12369368 |
| 39 | activation of protein kinase A activity (GO:0034199) | 4.07831652 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 4.07177730 |
| 41 | endosome to pigment granule transport (GO:0043485) | 4.06030179 |
| 42 | endosome to melanosome transport (GO:0035646) | 4.06030179 |
| 43 | chondroitin sulfate catabolic process (GO:0030207) | 3.98505485 |
| 44 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.97974233 |
| 45 | neuronal action potential propagation (GO:0019227) | 3.96424045 |
| 46 | L-serine transport (GO:0015825) | 3.96366478 |
| 47 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.91349322 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.90255649 |
| 49 | endothelial cell morphogenesis (GO:0001886) | 3.90054297 |
| 50 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.85437231 |
| 51 | sodium ion export (GO:0071436) | 3.84591753 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 3.78645161 |
| 53 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.77692181 |
| 54 | neuromuscular process controlling balance (GO:0050885) | 3.77128984 |
| 55 | synaptic transmission, glutamatergic (GO:0035249) | 3.74933238 |
| 56 | neuromuscular process controlling posture (GO:0050884) | 3.73202715 |
| 57 | serine transport (GO:0032329) | 3.65368352 |
| 58 | neurotransmitter transport (GO:0006836) | 3.65312013 |
| 59 | positive regulation of neuroblast proliferation (GO:0002052) | 3.64878029 |
| 60 | cerebellar Purkinje cell layer development (GO:0021680) | 3.58789719 |
| 61 | positive regulation of membrane potential (GO:0045838) | 3.58147093 |
| 62 | negative regulation of macroautophagy (GO:0016242) | 3.56572127 |
| 63 | long-term memory (GO:0007616) | 3.49562967 |
| 64 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.49242034 |
| 65 | suckling behavior (GO:0001967) | 3.48550881 |
| 66 | amyloid precursor protein metabolic process (GO:0042982) | 3.48482911 |
| 67 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.45916329 |
| 68 | neuron-neuron synaptic transmission (GO:0007270) | 3.44512759 |
| 69 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.44148684 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.44070173 |
| 71 | cAMP biosynthetic process (GO:0006171) | 3.43666259 |
| 72 | glutamate receptor signaling pathway (GO:0007215) | 3.41956532 |
| 73 | transferrin transport (GO:0033572) | 3.40469435 |
| 74 | regulation of synaptic plasticity (GO:0048167) | 3.40386796 |
| 75 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.36570811 |
| 76 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.35066180 |
| 77 | regulation of neurotransmitter secretion (GO:0046928) | 3.32891856 |
| 78 | innervation (GO:0060384) | 3.32279838 |
| 79 | lung morphogenesis (GO:0060425) | 3.31812648 |
| 80 | cell communication by electrical coupling (GO:0010644) | 3.30948309 |
| 81 | semaphorin-plexin signaling pathway (GO:0071526) | 3.30257001 |
| 82 | neuron recognition (GO:0008038) | 3.30183407 |
| 83 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.29374486 |
| 84 | regulation of postsynaptic membrane potential (GO:0060078) | 3.28299356 |
| 85 | peptidyl-proline hydroxylation (GO:0019511) | 3.28142296 |
| 86 | regulation of early endosome to late endosome transport (GO:2000641) | 3.27867250 |
| 87 | postsynaptic membrane organization (GO:0001941) | 3.27636624 |
| 88 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.27482291 |
| 89 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.27482291 |
| 90 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.27076948 |
| 91 | auditory behavior (GO:0031223) | 3.26845622 |
| 92 | response to auditory stimulus (GO:0010996) | 3.25171982 |
| 93 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.24233612 |
| 94 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.24163550 |
| 95 | dermatan sulfate biosynthetic process (GO:0030208) | 3.23859000 |
| 96 | vesicle transport along microtubule (GO:0047496) | 3.23402066 |
| 97 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.23355086 |
| 98 | oligodendrocyte differentiation (GO:0048709) | 3.23233318 |
| 99 | alanine transport (GO:0032328) | 3.22710378 |
| 100 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.21733868 |
| 101 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.20398067 |
| 102 | negative regulation of microtubule polymerization (GO:0031115) | 3.19951316 |
| 103 | prepulse inhibition (GO:0060134) | 3.18691498 |
| 104 | cell migration in hindbrain (GO:0021535) | 3.17306539 |
| 105 | transmission of nerve impulse (GO:0019226) | 3.14832326 |
| 106 | regulation of vesicle fusion (GO:0031338) | 3.14239595 |
| 107 | regulation of neurotransmitter transport (GO:0051588) | 3.14087631 |
| 108 | ferric iron transport (GO:0015682) | 3.12583550 |
| 109 | trivalent inorganic cation transport (GO:0072512) | 3.12583550 |
| 110 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.12432339 |
| 111 | neuronal ion channel clustering (GO:0045161) | 3.12372649 |
| 112 | mating behavior (GO:0007617) | 3.12080855 |
| 113 | dendritic spine organization (GO:0097061) | 3.09672115 |
| 114 | intraspecies interaction between organisms (GO:0051703) | 3.09371378 |
| 115 | social behavior (GO:0035176) | 3.09371378 |
| 116 | regulation of ARF protein signal transduction (GO:0032012) | 3.08736278 |
| 117 | neuroepithelial cell differentiation (GO:0060563) | 3.08330353 |
| 118 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.07701571 |
| 119 | adhesion of symbiont to host (GO:0044406) | 3.07429024 |
| 120 | positive regulation of neurotransmitter transport (GO:0051590) | 3.07401752 |
| 121 | dendrite morphogenesis (GO:0048813) | 3.07028490 |
| 122 | dermatan sulfate metabolic process (GO:0030205) | 3.06726537 |
| 123 | secondary metabolic process (GO:0019748) | 3.06451122 |
| 124 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.05967461 |
| 125 | axonal fasciculation (GO:0007413) | 3.04908862 |
| 126 | positive regulation of protein dephosphorylation (GO:0035307) | 3.04803135 |
| 127 | synaptic vesicle endocytosis (GO:0048488) | 3.03453834 |
| 128 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.03084039 |
| 129 | positive regulation of synapse maturation (GO:0090129) | 3.02824324 |
| 130 | long-term synaptic potentiation (GO:0060291) | 3.02716437 |
| 131 | regulation of female receptivity (GO:0045924) | 3.01935334 |
| 132 | membrane protein ectodomain proteolysis (GO:0006509) | 3.01889752 |
| 133 | virion attachment to host cell (GO:0019062) | 3.00621994 |
| 134 | adhesion of symbiont to host cell (GO:0044650) | 3.00621994 |
| 135 | neuromuscular process (GO:0050905) | 2.99535054 |
| 136 | negative regulation of catenin import into nucleus (GO:0035414) | 2.99127814 |
| 137 | regulation of gonadotropin secretion (GO:0032276) | 2.98429703 |
| 138 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96565477 |
| 139 | positive regulation of synaptic transmission (GO:0050806) | 2.96079925 |
| 140 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.96043423 |
| 141 | axon cargo transport (GO:0008088) | 2.95495488 |
| 142 | glycosphingolipid catabolic process (GO:0046479) | 2.95468761 |
| 143 | protein maturation by protein folding (GO:0022417) | 2.94847701 |
| 144 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.92133312 |
| 145 | positive regulation of axon extension (GO:0045773) | 2.90115177 |
| 146 | regulation of synaptic transmission (GO:0050804) | 2.88943814 |
| 147 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.88858963 |
| 148 | pigment biosynthetic process (GO:0046148) | 2.87642737 |
| 149 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.87517002 |
| 150 | glial cell migration (GO:0008347) | 2.87249584 |
| 151 | regulation of glutamate secretion (GO:0014048) | 2.86928101 |
| 152 | axon regeneration (GO:0031103) | 2.86254643 |
| 153 | organelle transport along microtubule (GO:0072384) | 2.84566073 |
| 154 | skin morphogenesis (GO:0043589) | 2.84189362 |
| 155 | membrane depolarization during action potential (GO:0086010) | 2.83898359 |
| 156 | learning (GO:0007612) | 2.83665457 |
| 157 | membrane hyperpolarization (GO:0060081) | 2.82344890 |
| 158 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.82268675 |
| 159 | response to parathyroid hormone (GO:0071107) | 2.82226347 |
| 160 | dopamine receptor signaling pathway (GO:0007212) | 2.81996091 |
| 161 | membrane depolarization (GO:0051899) | 2.81690893 |
| 162 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.81560128 |
| 163 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.80242310 |
| 164 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.75255394 |
| 165 | negative regulation of glycogen metabolic process (GO:0070874) | 2.73203176 |
| 166 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.72942242 |
| 167 | glycolipid catabolic process (GO:0019377) | 2.71701335 |
| 168 | purine nucleotide transport (GO:0015865) | 2.70468372 |
| 169 | protein insertion into membrane (GO:0051205) | 2.68967140 |
| 170 | protein localization to endosome (GO:0036010) | 2.66019237 |
| 171 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.65313009 |
| 172 | protein heterotrimerization (GO:0070208) | 2.64445562 |
| 173 | basic amino acid transport (GO:0015802) | 2.62035898 |
| 174 | mitochondrion transport along microtubule (GO:0047497) | 2.54890191 |
| 175 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.54890191 |
| 176 | axon development (GO:0061564) | 2.54739700 |
| 177 | purine ribonucleotide transport (GO:0015868) | 2.54047008 |
| 178 | GDP-mannose metabolic process (GO:0019673) | 2.53221254 |
| 179 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.51370221 |
| 180 | melanin biosynthetic process (GO:0042438) | 12.6353007 |
| 181 | melanin metabolic process (GO:0006582) | 11.6516624 |
| 182 | secondary metabolite biosynthetic process (GO:0044550) | 10.2588027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.72483173 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.01335070 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08809474 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04747249 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00780809 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.97518900 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.91081144 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.82405479 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.80858619 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.80858619 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.75087771 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.67705991 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.63137031 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.59309414 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.56321801 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55817589 |
| 17 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.54159584 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53614088 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51197475 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.49292956 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.48163208 |
| 22 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.45589799 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.42690793 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.39924459 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.38587628 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.28883106 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.25995462 |
| 28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.25563226 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22598662 |
| 30 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.13052004 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.10562533 |
| 32 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.05892241 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04101267 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.03796124 |
| 35 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.00593193 |
| 36 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.93734051 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81816805 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80461272 |
| 39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.77289756 |
| 40 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.75614201 |
| 41 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.74105848 |
| 42 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.72554867 |
| 43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.70667549 |
| 44 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.68321526 |
| 45 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.68020555 |
| 46 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.63756359 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62896945 |
| 48 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.62798995 |
| 49 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.61280886 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.57889245 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56306929 |
| 52 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.54634606 |
| 53 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.52001727 |
| 54 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.51412654 |
| 55 | SA1_27219007_Chip-Seq_Bcells_Human | 1.51338917 |
| 56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.49947429 |
| 57 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48779880 |
| 58 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47569825 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46666194 |
| 60 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45622103 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43966418 |
| 62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43666273 |
| 63 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.43466995 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40397187 |
| 65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39846522 |
| 66 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39186041 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.38336123 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38225758 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33772711 |
| 70 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.32579014 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.31762638 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.31494558 |
| 73 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30504919 |
| 74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30433835 |
| 75 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.30333618 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26319884 |
| 77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24840025 |
| 78 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.24520179 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24484111 |
| 80 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23108513 |
| 81 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22104525 |
| 82 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.22014383 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21644752 |
| 84 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.21069424 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17556385 |
| 86 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.17211304 |
| 87 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.16251090 |
| 88 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.15748006 |
| 89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15056328 |
| 90 | AR_19668381_ChIP-Seq_PC3_Human | 1.14669498 |
| 91 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.13389402 |
| 92 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12261029 |
| 93 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11097935 |
| 94 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.10878683 |
| 95 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.10829226 |
| 96 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.10101444 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09519072 |
| 98 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09373532 |
| 99 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09229266 |
| 100 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09225441 |
| 101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09208529 |
| 102 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.08849902 |
| 103 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.08546135 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08032264 |
| 105 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.06800756 |
| 106 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.06362891 |
| 107 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.05321958 |
| 108 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.04907714 |
| 109 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04609787 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.03880476 |
| 111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03307681 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03208693 |
| 113 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02220782 |
| 114 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01571241 |
| 115 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99080598 |
| 116 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.98914591 |
| 117 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97598943 |
| 118 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96202459 |
| 119 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95566437 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94917786 |
| 121 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94578813 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94281217 |
| 123 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94210868 |
| 124 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92420215 |
| 125 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92374660 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92221256 |
| 127 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91417678 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91069177 |
| 129 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89678119 |
| 130 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89532533 |
| 131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89213871 |
| 132 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.88774274 |
| 133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88086166 |
| 134 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87027837 |
| 135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86843233 |
| 136 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86025047 |
| 137 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85364054 |
| 138 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85112286 |
| 139 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84226594 |
| 140 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83394459 |
| 141 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.82591037 |
| 142 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81667659 |
| 143 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81295000 |
| 144 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.79516590 |
| 145 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79507881 |
| 146 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.78530189 |
| 147 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.78206411 |
| 148 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.78174465 |
| 149 | TCF4_23295773_ChIP-Seq_U87_Human | 0.78160474 |
| 150 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77975146 |
| 151 | TP53_16413492_ChIP-PET_HCT116_Human | 0.77671072 |
| 152 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.76575653 |
| 153 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.76244493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 6.98033233 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 6.45578008 |
| 3 | MP0000372_irregular_coat_pigmentation | 6.05968971 |
| 4 | MP0005257_abnormal_intraocular_pressure | 5.38650588 |
| 5 | MP0003136_yellow_coat_color | 5.10372405 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 5.07894571 |
| 7 | MP0005408_hypopigmentation | 4.93248693 |
| 8 | * MP0003635_abnormal_synaptic_transmissio | 4.02095023 |
| 9 | MP0003880_abnormal_central_pattern | 3.83980499 |
| 10 | MP0004270_analgesia | 3.49566715 |
| 11 | MP0005409_darkened_coat_color | 3.48105247 |
| 12 | MP0004381_abnormal_hair_follicle | 3.46264758 |
| 13 | MP0009745_abnormal_behavioral_response | 3.25316755 |
| 14 | * MP0002063_abnormal_learning/memory/cond | 3.12350642 |
| 15 | MP0002822_catalepsy | 3.00307544 |
| 16 | MP0002064_seizures | 2.97733692 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 2.96623326 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.85283403 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.77595090 |
| 20 | MP0004858_abnormal_nervous_system | 2.76993955 |
| 21 | MP0009046_muscle_twitch | 2.70408669 |
| 22 | MP0004272_abnormal_basement_membrane | 2.69400658 |
| 23 | MP0002909_abnormal_adrenal_gland | 2.60373476 |
| 24 | MP0000015_abnormal_ear_pigmentation | 2.58390786 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 2.56563459 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.52497205 |
| 27 | MP0005645_abnormal_hypothalamus_physiol | 2.44663394 |
| 28 | MP0009840_abnormal_foam_cell | 2.40370323 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 2.32762911 |
| 30 | MP0003122_maternal_imprinting | 2.31152891 |
| 31 | MP0001501_abnormal_sleep_pattern | 2.27426020 |
| 32 | MP0002272_abnormal_nervous_system | 2.26264263 |
| 33 | MP0005058_abnormal_lysosome_morphology | 2.17670088 |
| 34 | MP0001486_abnormal_startle_reflex | 2.15482938 |
| 35 | MP0000371_diluted_coat_color | 2.12689436 |
| 36 | MP0002733_abnormal_thermal_nociception | 2.03368966 |
| 37 | MP0002735_abnormal_chemical_nociception | 2.02652181 |
| 38 | MP0002075_abnormal_coat/hair_pigmentati | 1.99274303 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.98960041 |
| 40 | MP0003329_amyloid_beta_deposits | 1.97093650 |
| 41 | MP0001970_abnormal_pain_threshold | 1.94470871 |
| 42 | MP0002736_abnormal_nociception_after | 1.93233342 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.90770729 |
| 44 | MP0002184_abnormal_innervation | 1.79542277 |
| 45 | MP0002095_abnormal_skin_pigmentation | 1.78633483 |
| 46 | MP0008569_lethality_at_weaning | 1.72068184 |
| 47 | MP0003787_abnormal_imprinting | 1.68830433 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.68063042 |
| 49 | MP0000955_abnormal_spinal_cord | 1.65417323 |
| 50 | MP0001186_pigmentation_phenotype | 1.64897366 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.61344396 |
| 52 | MP0000778_abnormal_nervous_system | 1.58384441 |
| 53 | MP0003283_abnormal_digestive_organ | 1.57024626 |
| 54 | MP0004885_abnormal_endolymph | 1.56459504 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 1.51632535 |
| 56 | MP0001849_ear_inflammation | 1.51201683 |
| 57 | MP0004924_abnormal_behavior | 1.49324442 |
| 58 | MP0005386_behavior/neurological_phenoty | 1.49324442 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.43565498 |
| 60 | MP0005646_abnormal_pituitary_gland | 1.41447873 |
| 61 | MP0003879_abnormal_hair_cell | 1.40631327 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.40183720 |
| 63 | MP0002938_white_spotting | 1.38361081 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.36360598 |
| 65 | MP0002882_abnormal_neuron_morphology | 1.35435260 |
| 66 | * MP0002066_abnormal_motor_capabilities/c | 1.32949779 |
| 67 | MP0003633_abnormal_nervous_system | 1.30464702 |
| 68 | MP0003011_delayed_dark_adaptation | 1.28750849 |
| 69 | MP0001529_abnormal_vocalization | 1.22482714 |
| 70 | MP0003123_paternal_imprinting | 1.22327751 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 1.21562586 |
| 72 | MP0003075_altered_response_to | 1.21450262 |
| 73 | MP0005623_abnormal_meninges_morphology | 1.17883745 |
| 74 | MP0008872_abnormal_physiological_respon | 1.15181089 |
| 75 | MP0000569_abnormal_digit_pigmentation | 1.10342313 |
| 76 | MP0001324_abnormal_eye_pigmentation | 1.09783736 |
| 77 | MP0000751_myopathy | 1.08832440 |
| 78 | MP0001984_abnormal_olfaction | 1.08729500 |
| 79 | MP0003631_nervous_system_phenotype | 1.07186994 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.05626921 |
| 81 | MP0002152_abnormal_brain_morphology | 1.03524273 |
| 82 | MP0002069_abnormal_eating/drinking_beha | 1.02034580 |
| 83 | MP0004233_abnormal_muscle_weight | 1.01386014 |
| 84 | * MP0001502_abnormal_circadian_rhythm | 1.00964694 |
| 85 | MP0002653_abnormal_ependyma_morphology | 1.00962017 |
| 86 | MP0004142_abnormal_muscle_tone | 0.99783641 |
| 87 | MP0002060_abnormal_skin_morphology | 0.97922856 |
| 88 | MP0001905_abnormal_dopamine_level | 0.95518666 |
| 89 | MP0001177_atelectasis | 0.93093041 |
| 90 | MP0003634_abnormal_glial_cell | 0.91228242 |
| 91 | MP0002229_neurodegeneration | 0.91047302 |
| 92 | MP0002090_abnormal_vision | 0.90667129 |
| 93 | MP0008874_decreased_physiological_sensi | 0.88672676 |
| 94 | MP0003690_abnormal_glial_cell | 0.87358748 |
| 95 | MP0000604_amyloidosis | 0.87172226 |
| 96 | MP0003045_fibrosis | 0.87015079 |
| 97 | MP0010234_abnormal_vibrissa_follicle | 0.84061600 |
| 98 | MP0004043_abnormal_pH_regulation | 0.83032449 |
| 99 | MP0010386_abnormal_urinary_bladder | 0.82596209 |
| 100 | MP0001915_intracranial_hemorrhage | 0.80848909 |
| 101 | MP0001299_abnormal_eye_distance/ | 0.79619397 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.78344893 |
| 103 | MP0002751_abnormal_autonomic_nervous | 0.78078023 |
| 104 | MP0003632_abnormal_nervous_system | 0.77646054 |
| 105 | * MP0008961_abnormal_basal_metabolism | 0.76668370 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.75703545 |
| 107 | MP0003121_genomic_imprinting | 0.75082092 |
| 108 | MP0008770_decreased_survivor_rate | 0.74975982 |
| 109 | MP0000920_abnormal_myelination | 0.74952947 |
| 110 | MP0004085_abnormal_heartbeat | 0.74884576 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.74382908 |
| 112 | MP0005535_abnormal_body_temperature | 0.74281882 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.73699090 |
| 114 | MP0005499_abnormal_olfactory_system | 0.72612072 |
| 115 | MP0005394_taste/olfaction_phenotype | 0.72612072 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.72077657 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.70888216 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.70780763 |
| 119 | MP0005197_abnormal_uvea_morphology | 0.69221174 |
| 120 | MP0001664_abnormal_digestion | 0.68700481 |
| 121 | MP0005503_abnormal_tendon_morphology | 0.66698167 |
| 122 | MP0000631_abnormal_neuroendocrine_gland | 0.66669474 |
| 123 | MP0000534_abnormal_ureter_morphology | 0.66134786 |
| 124 | MP0005451_abnormal_body_composition | 0.64594858 |
| 125 | MP0000579_abnormal_nail_morphology | 0.63708103 |
| 126 | MP0001188_hyperpigmentation | 0.63061610 |
| 127 | MP0004130_abnormal_muscle_cell | 0.61804526 |
| 128 | MP0003646_muscle_fatigue | 0.60788242 |
| 129 | MP0000750_abnormal_muscle_regeneration | 0.60772765 |
| 130 | MP0000747_muscle_weakness | 0.60711339 |
| 131 | MP0002752_abnormal_somatic_nervous | 0.60685968 |
| 132 | MP0004484_altered_response_of | 0.59179907 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.56956571 |
| 134 | MP0000358_abnormal_cell_content/ | 0.52593403 |
| 135 | MP0003385_abnormal_body_wall | 0.50991400 |
| 136 | MP0009672_abnormal_birth_weight | 0.46507588 |
| 137 | MP0000367_abnormal_coat/_hair | 0.46045418 |
| 138 | MP0000462_abnormal_digestive_system | 0.45574462 |
| 139 | MP0005248_abnormal_Harderian_gland | 0.45040411 |
| 140 | MP0002177_abnormal_outer_ear | 0.43447617 |
| 141 | MP0009250_abnormal_appendicular_skeleto | 0.41123041 |
| 142 | MP0005174_abnormal_tail_pigmentation | 0.40270122 |
| 143 | MP0000681_abnormal_thyroid_gland | 0.38905097 |
| 144 | MP0009053_abnormal_anal_canal | 0.38718290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 9.24223925 |
| 2 | Hypoplasia of the fovea (HP:0007750) | 9.24223925 |
| 3 | Aplasia/Hypoplasia of the macula (HP:0008059) | 8.70366782 |
| 4 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 8.17386521 |
| 5 | Abnormality of the fovea (HP:0000493) | 7.34122285 |
| 6 | Myokymia (HP:0002411) | 6.52846029 |
| 7 | Focal motor seizures (HP:0011153) | 6.03864344 |
| 8 | Anterior segment dysgenesis (HP:0007700) | 5.18072252 |
| 9 | Visual hallucinations (HP:0002367) | 5.15318540 |
| 10 | Ocular albinism (HP:0001107) | 5.06954820 |
| 11 | Blue irides (HP:0000635) | 5.00637121 |
| 12 | Focal seizures (HP:0007359) | 4.98941019 |
| 13 | J-shaped sella turcica (HP:0002680) | 4.92508496 |
| 14 | Hand muscle atrophy (HP:0009130) | 4.58801966 |
| 15 | White forelock (HP:0002211) | 4.57977144 |
| 16 | Iris hypopigmentation (HP:0007730) | 4.57757586 |
| 17 | Patchy hypopigmentation of hair (HP:0011365) | 4.18856346 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.12220085 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.12220085 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 4.12220085 |
| 21 | Peripheral hypomyelination (HP:0007182) | 4.10727778 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 4.06416752 |
| 23 | Distal upper limb amyotrophy (HP:0007149) | 3.93998630 |
| 24 | Upper limb amyotrophy (HP:0009129) | 3.93998630 |
| 25 | Hypopigmentation of the fundus (HP:0007894) | 3.91201414 |
| 26 | Large eyes (HP:0001090) | 3.88864869 |
| 27 | Ankle clonus (HP:0011448) | 3.87841083 |
| 28 | Atonic seizures (HP:0010819) | 3.77366554 |
| 29 | Epileptic encephalopathy (HP:0200134) | 3.74824680 |
| 30 | Action tremor (HP:0002345) | 3.69422453 |
| 31 | Depression (HP:0000716) | 3.58792762 |
| 32 | Absence seizures (HP:0002121) | 3.53854266 |
| 33 | Paraparesis (HP:0002385) | 3.52275406 |
| 34 | Generalized tonic-clonic seizures (HP:0002069) | 3.46472241 |
| 35 | Cerebral aneurysm (HP:0004944) | 3.45894519 |
| 36 | Pheochromocytoma (HP:0002666) | 3.43500652 |
| 37 | Febrile seizures (HP:0002373) | 3.40916181 |
| 38 | Spastic paraparesis (HP:0002313) | 3.39807219 |
| 39 | Papilledema (HP:0001085) | 3.39405029 |
| 40 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.38351294 |
| 41 | Hypercortisolism (HP:0001578) | 3.35837036 |
| 42 | Progressive cerebellar ataxia (HP:0002073) | 3.35144410 |
| 43 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.34056400 |
| 44 | Agitation (HP:0000713) | 3.33259574 |
| 45 | Shallow orbits (HP:0000586) | 3.28154782 |
| 46 | Cerebral hypomyelination (HP:0006808) | 3.22664652 |
| 47 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.22440434 |
| 48 | Mutism (HP:0002300) | 3.18848239 |
| 49 | Heterochromia iridis (HP:0001100) | 3.17425991 |
| 50 | Dialeptic seizures (HP:0011146) | 3.15830228 |
| 51 | Achilles tendon contracture (HP:0001771) | 3.15789288 |
| 52 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.15312341 |
| 53 | Anxiety (HP:0000739) | 3.11921865 |
| 54 | Abnormality of the lower motor neuron (HP:0002366) | 3.08778193 |
| 55 | Akinesia (HP:0002304) | 3.07735356 |
| 56 | Poor eye contact (HP:0000817) | 3.05493259 |
| 57 | Alacrima (HP:0000522) | 3.02981060 |
| 58 | Postural instability (HP:0002172) | 2.99612437 |
| 59 | Premature rupture of membranes (HP:0001788) | 2.98486087 |
| 60 | Amblyopia (HP:0000646) | 2.95299178 |
| 61 | Impaired social interactions (HP:0000735) | 2.93191270 |
| 62 | Abnormal social behavior (HP:0012433) | 2.93191270 |
| 63 | Neuroendocrine neoplasm (HP:0100634) | 2.90667343 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.82714087 |
| 65 | Abnormality of the Achilles tendon (HP:0005109) | 2.81962540 |
| 66 | Abnormal eating behavior (HP:0100738) | 2.81448022 |
| 67 | Neurofibrillary tangles (HP:0002185) | 2.79884586 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.79228337 |
| 69 | Hypokinesia (HP:0002375) | 2.75644623 |
| 70 | Truncal ataxia (HP:0002078) | 2.73687737 |
| 71 | Loss of speech (HP:0002371) | 2.73404136 |
| 72 | Ventricular fibrillation (HP:0001663) | 2.73310701 |
| 73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.68775672 |
| 74 | Absent epiphyses (HP:0010577) | 2.68201276 |
| 75 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.68201276 |
| 76 | Urinary urgency (HP:0000012) | 2.67750422 |
| 77 | Dysdiadochokinesis (HP:0002075) | 2.66446378 |
| 78 | Failure to thrive in infancy (HP:0001531) | 2.66333119 |
| 79 | Insomnia (HP:0100785) | 2.64149457 |
| 80 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.64141141 |
| 81 | Hyperacusis (HP:0010780) | 2.63868394 |
| 82 | Dysmetria (HP:0001310) | 2.63719493 |
| 83 | Genu recurvatum (HP:0002816) | 2.63192528 |
| 84 | Torticollis (HP:0000473) | 2.61515686 |
| 85 | Spastic gait (HP:0002064) | 2.60110042 |
| 86 | Genetic anticipation (HP:0003743) | 2.57552315 |
| 87 | Esotropia (HP:0000565) | 2.54113067 |
| 88 | Vertebral compression fractures (HP:0002953) | 2.53897651 |
| 89 | Distal lower limb muscle weakness (HP:0009053) | 2.53677579 |
| 90 | Hypoventilation (HP:0002791) | 2.51567052 |
| 91 | Menstrual irregularities (HP:0000858) | 2.50869342 |
| 92 | Broad-based gait (HP:0002136) | 2.47574369 |
| 93 | Deformed sella turcica (HP:0002681) | 2.43708108 |
| 94 | Hypoplasia of the iris (HP:0007676) | 2.43435273 |
| 95 | Termporal pattern (HP:0011008) | 2.43106909 |
| 96 | Insidious onset (HP:0003587) | 2.43106909 |
| 97 | Abnormality of the corticospinal tract (HP:0002492) | 2.40419436 |
| 98 | Bradykinesia (HP:0002067) | 2.39226852 |
| 99 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.37243608 |
| 100 | Focal dystonia (HP:0004373) | 2.35881658 |
| 101 | Impaired smooth pursuit (HP:0007772) | 2.34962201 |
| 102 | Posterior embryotoxon (HP:0000627) | 2.34243317 |
| 103 | Morphological abnormality of the inner ear (HP:0011390) | 2.33033416 |
| 104 | Excessive salivation (HP:0003781) | 2.32330921 |
| 105 | Drooling (HP:0002307) | 2.32330921 |
| 106 | Bulbar palsy (HP:0001283) | 2.31580731 |
| 107 | Megalencephaly (HP:0001355) | 2.30627251 |
| 108 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.27504445 |
| 109 | Gaze-evoked nystagmus (HP:0000640) | 2.26737279 |
| 110 | Intention tremor (HP:0002080) | 2.26192858 |
| 111 | Abnormality of binocular vision (HP:0011514) | 2.25767561 |
| 112 | Diplopia (HP:0000651) | 2.25767561 |
| 113 | Neuronal loss in central nervous system (HP:0002529) | 2.25348108 |
| 114 | Lower limb muscle weakness (HP:0007340) | 2.24234653 |
| 115 | Abnormality of the line of Schwalbe (HP:0008048) | 2.23578614 |
| 116 | Hemiplegia (HP:0002301) | 2.20930034 |
| 117 | Hyperthyroidism (HP:0000836) | 2.20540835 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 2.19703572 |
| 119 | Abnormality of the anterior chamber (HP:0000593) | 2.19307586 |
| 120 | Decreased lacrimation (HP:0000633) | 2.18501399 |
| 121 | Stereotypic behavior (HP:0000733) | 2.17424641 |
| 122 | Progressive inability to walk (HP:0002505) | 2.16929186 |
| 123 | Turricephaly (HP:0000262) | 2.16361547 |
| 124 | Craniofacial dystonia (HP:0012179) | 2.14914373 |
| 125 | Epileptiform EEG discharges (HP:0011182) | 2.14441526 |
| 126 | Elfin facies (HP:0004428) | 2.13928307 |
| 127 | EEG with generalized epileptiform discharges (HP:0011198) | 2.12862270 |
| 128 | Macroorchidism (HP:0000053) | 2.12379477 |
| 129 | Pointed chin (HP:0000307) | 2.11934567 |
| 130 | Overriding aorta (HP:0002623) | 2.09881015 |
| 131 | Hypsarrhythmia (HP:0002521) | 2.09683370 |
| 132 | Polyphagia (HP:0002591) | 2.09149571 |
| 133 | Rapidly progressive (HP:0003678) | 2.08774106 |
| 134 | Ankyloglossia (HP:0010296) | 2.08099066 |
| 135 | Generalized hypopigmentation (HP:0007513) | 2.07783590 |
| 136 | Hemiparesis (HP:0001269) | 2.07000575 |
| 137 | Enlarged penis (HP:0000040) | 2.06703135 |
| 138 | Resting tremor (HP:0002322) | 2.06553749 |
| 139 | Clonus (HP:0002169) | 2.06487978 |
| 140 | Apathy (HP:0000741) | 2.05790444 |
| 141 | Hyperparathyroidism (HP:0000843) | 2.05719144 |
| 142 | Anosmia (HP:0000458) | 2.03979580 |
| 143 | Bundle branch block (HP:0011710) | 2.03559951 |
| 144 | Diminished movement (HP:0002374) | 2.03286171 |
| 145 | Abnormality of dentin (HP:0010299) | 2.03088123 |
| 146 | Trismus (HP:0000211) | 2.02686348 |
| 147 | Increased variability in muscle fiber diameter (HP:0003557) | 2.01806171 |
| 148 | Annular pancreas (HP:0001734) | 2.01098413 |
| 149 | Lower limb amyotrophy (HP:0007210) | 2.00459973 |
| 150 | Buphthalmos (HP:0000557) | 1.99145801 |
| 151 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.98601966 |
| 152 | Generalized myoclonic seizures (HP:0002123) | 1.95783331 |
| 153 | Impaired vibratory sensation (HP:0002495) | 1.94650394 |
| 154 | Psychosis (HP:0000709) | 1.94070900 |
| 155 | Hyperventilation (HP:0002883) | 1.93824629 |
| 156 | Premature graying of hair (HP:0002216) | 1.93539096 |
| 157 | Bladder diverticulum (HP:0000015) | 1.92016073 |
| 158 | Dysmetric saccades (HP:0000641) | 1.90776313 |
| 159 | Status epilepticus (HP:0002133) | 1.90592736 |
| 160 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.89739547 |
| 161 | Amyotrophic lateral sclerosis (HP:0007354) | 1.88710987 |
| 162 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.88702429 |
| 163 | Delusions (HP:0000746) | 1.87371339 |
| 164 | Abnormal EKG (HP:0003115) | 1.86110002 |
| 165 | Restlessness (HP:0000711) | 1.85898627 |
| 166 | Diminished motivation (HP:0000745) | 1.85710879 |
| 167 | Nasal polyposis (HP:0100582) | 1.84723242 |
| 168 | Pathologic fracture (HP:0002756) | 1.83644890 |
| 169 | Scanning speech (HP:0002168) | 1.82748965 |
| 170 | Abnormal auditory evoked potentials (HP:0006958) | 1.79404647 |
| 171 | Spinal rigidity (HP:0003306) | 1.79231640 |
| 172 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.78870644 |
| 173 | Abnormality of the nasal mucosa (HP:0000433) | 1.78567321 |
| 174 | Upper limb muscle weakness (HP:0003484) | 1.77871931 |
| 175 | Elbow flexion contracture (HP:0002987) | 1.75398025 |
| 176 | Renovascular hypertension (HP:0100817) | 1.73685946 |
| 177 | Pustule (HP:0200039) | 1.72124944 |
| 178 | Poor head control (HP:0002421) | 1.71926044 |
| 179 | Cholecystitis (HP:0001082) | 1.67426070 |
| 180 | Abnormal gallbladder physiology (HP:0012438) | 1.67426070 |
| 181 | CNS hypomyelination (HP:0003429) | 1.67079422 |
| 182 | Mesangial abnormality (HP:0001966) | 1.66597515 |
| 183 | Premature skin wrinkling (HP:0100678) | 1.65062067 |
| 184 | Retinal atrophy (HP:0001105) | 1.64579404 |
| 185 | Prostate neoplasm (HP:0100787) | 1.63545589 |
| 186 | Abnormality of the salivary glands (HP:0010286) | 1.62151798 |
| 187 | Aqueductal stenosis (HP:0002410) | 1.57581372 |
| 188 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.56697396 |
| 189 | Abnormality of the musculature of the hand (HP:0001421) | 1.53592096 |
| 190 | Renal duplication (HP:0000075) | 1.52632205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.65039486 |
| 2 | NTRK3 | 4.57370514 |
| 3 | EPHA4 | 3.71914296 |
| 4 | MAPKAPK3 | 3.50950675 |
| 5 | NTRK1 | 2.82924710 |
| 6 | SCYL2 | 2.73790162 |
| 7 | MARK1 | 2.69030229 |
| 8 | PRKD3 | 2.64940039 |
| 9 | MAP3K4 | 2.64777149 |
| 10 | MINK1 | 2.61638841 |
| 11 | PAK6 | 2.50934882 |
| 12 | DAPK2 | 2.48492042 |
| 13 | TESK1 | 2.44410652 |
| 14 | LIMK1 | 2.37196975 |
| 15 | KSR2 | 2.27773685 |
| 16 | NTRK2 | 2.22310986 |
| 17 | TESK2 | 2.10442504 |
| 18 | CAMKK1 | 2.01477529 |
| 19 | MAP3K11 | 1.94422232 |
| 20 | MAP2K7 | 1.89612117 |
| 21 | CSNK1G3 | 1.87879048 |
| 22 | ERN1 | 1.86600194 |
| 23 | MAP3K3 | 1.69741525 |
| 24 | PKN2 | 1.67542505 |
| 25 | MAP2K4 | 1.66472465 |
| 26 | ALK | 1.64636205 |
| 27 | MAP3K2 | 1.63675309 |
| 28 | CSNK1A1L | 1.62682136 |
| 29 | CDK5 | 1.56105126 |
| 30 | UHMK1 | 1.52976883 |
| 31 | NME2 | 1.48487663 |
| 32 | CSNK1G1 | 1.45783552 |
| 33 | MAP3K12 | 1.44074985 |
| 34 | TAOK1 | 1.39925167 |
| 35 | DMPK | 1.37633042 |
| 36 | RET | 1.34189044 |
| 37 | GRK5 | 1.34171897 |
| 38 | KSR1 | 1.33096522 |
| 39 | BRAF | 1.32808091 |
| 40 | TYRO3 | 1.30564348 |
| 41 | DAPK1 | 1.29156151 |
| 42 | EPHB1 | 1.26528058 |
| 43 | EPHA3 | 1.25546595 |
| 44 | LATS2 | 1.25502744 |
| 45 | DYRK2 | 1.25196030 |
| 46 | STK38 | 1.23895967 |
| 47 | RIPK4 | 1.22196827 |
| 48 | ABL2 | 1.22151557 |
| 49 | ARAF | 1.21208864 |
| 50 | TAOK2 | 1.19668691 |
| 51 | PLK2 | 1.16546588 |
| 52 | PRKCH | 1.13753584 |
| 53 | FES | 1.11223527 |
| 54 | SIK1 | 1.10167668 |
| 55 | CDK19 | 1.10040415 |
| 56 | PNCK | 1.07591873 |
| 57 | CAMK1 | 1.05537284 |
| 58 | PRKCG | 1.05527713 |
| 59 | PAK3 | 1.05194224 |
| 60 | SIK3 | 1.04913952 |
| 61 | WEE1 | 1.02453035 |
| 62 | SIK2 | 1.00146889 |
| 63 | LMTK2 | 0.99972822 |
| 64 | STK11 | 0.96525423 |
| 65 | MAP3K13 | 0.96459205 |
| 66 | MAP2K2 | 0.92051576 |
| 67 | MAP3K6 | 0.89151754 |
| 68 | RIPK1 | 0.88820750 |
| 69 | PKN1 | 0.88254131 |
| 70 | TNIK | 0.87382400 |
| 71 | MAP3K1 | 0.85410635 |
| 72 | NEK1 | 0.84219178 |
| 73 | CDK14 | 0.83692213 |
| 74 | CDK15 | 0.83421884 |
| 75 | PHKG1 | 0.83270426 |
| 76 | PHKG2 | 0.83270426 |
| 77 | CAMK2A | 0.83233401 |
| 78 | CAMKK2 | 0.83109817 |
| 79 | CDK18 | 0.82674874 |
| 80 | MAPK12 | 0.80000704 |
| 81 | PRPF4B | 0.77002344 |
| 82 | EPHB2 | 0.74766810 |
| 83 | PRKD2 | 0.74432869 |
| 84 | SGK494 | 0.74402915 |
| 85 | SGK223 | 0.74402915 |
| 86 | CDK11A | 0.72592300 |
| 87 | MARK2 | 0.70888009 |
| 88 | MAPK13 | 0.70531777 |
| 89 | MTOR | 0.69592215 |
| 90 | PTK2 | 0.66572055 |
| 91 | FER | 0.66185441 |
| 92 | MARK3 | 0.65449758 |
| 93 | CSNK1G2 | 0.65242431 |
| 94 | PDGFRA | 0.64866771 |
| 95 | BRSK1 | 0.64316799 |
| 96 | RPS6KA2 | 0.63901894 |
| 97 | CASK | 0.61596773 |
| 98 | RAF1 | 0.60171563 |
| 99 | PRKG2 | 0.59704347 |
| 100 | DAPK3 | 0.58878327 |
| 101 | RPS6KB2 | 0.58374307 |
| 102 | ILK | 0.57980257 |
| 103 | STK16 | 0.57071530 |
| 104 | PDK1 | 0.56227850 |
| 105 | DDR2 | 0.55552667 |
| 106 | SGK3 | 0.55359232 |
| 107 | CDC42BPA | 0.55359120 |
| 108 | MAPK4 | 0.55263140 |
| 109 | EEF2K | 0.54809897 |
| 110 | PDPK1 | 0.54354840 |
| 111 | SGK1 | 0.53173818 |
| 112 | CAMK1G | 0.53155902 |
| 113 | GSK3A | 0.53135993 |
| 114 | PTK6 | 0.52814354 |
| 115 | MAPK10 | 0.52550548 |
| 116 | TNK2 | 0.50529821 |
| 117 | TTN | 0.50449511 |
| 118 | CDK7 | 0.49090718 |
| 119 | PAK1 | 0.48687520 |
| 120 | CAMK4 | 0.48230892 |
| 121 | RPS6KA3 | 0.47440010 |
| 122 | PAK4 | 0.47226864 |
| 123 | CAMK2B | 0.47115393 |
| 124 | FYN | 0.46657224 |
| 125 | TRIB3 | 0.46595351 |
| 126 | PINK1 | 0.46447606 |
| 127 | SGK2 | 0.45912091 |
| 128 | MAP2K1 | 0.45591411 |
| 129 | PTK2B | 0.44264790 |
| 130 | PIM2 | 0.42056039 |
| 131 | PRKCZ | 0.41738967 |
| 132 | ICK | 0.41684694 |
| 133 | AKT2 | 0.40299808 |
| 134 | PRKD1 | 0.39624881 |
| 135 | LRRK2 | 0.38862182 |
| 136 | ROCK2 | 0.38218259 |
| 137 | MAP3K7 | 0.37941121 |
| 138 | PRKCE | 0.36450592 |
| 139 | DYRK1A | 0.36440830 |
| 140 | ERBB4 | 0.36415916 |
| 141 | ROCK1 | 0.34775018 |
| 142 | CSNK1E | 0.34485458 |
| 143 | HIPK2 | 0.33867321 |
| 144 | TBK1 | 0.33419787 |
| 145 | NEK6 | 0.31467152 |
| 146 | MAPK8 | 0.30912155 |
| 147 | CAMK2G | 0.29281896 |
| 148 | CAMK2D | 0.29205709 |
| 149 | PDGFRB | 0.28165566 |
| 150 | SRC | 0.27696612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.59687471 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.13783887 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.75871686 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67213795 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.66029492 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.55891688 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.51919489 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.33176834 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.30266764 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.25403831 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.24977578 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.22357767 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.09558361 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.07788602 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.07391626 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.04242701 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03039369 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87914654 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87095569 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.79530391 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.78105834 |
| 22 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.67028278 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66560049 |
| 24 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.66380965 |
| 25 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.62733474 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.56548711 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.56053281 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.53486008 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47850381 |
| 30 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.46569486 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.42831222 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41514026 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.38703540 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.35751865 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34379131 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.32762767 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.30020735 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.27891106 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.27050276 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26796825 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.26614101 |
| 42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.26256196 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21799141 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21028567 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20094637 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16293956 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15149912 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14031025 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12824132 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 1.05705157 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04002736 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 1.03272462 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02792711 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02250492 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00636276 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99252126 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98858530 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 0.94983111 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.94205530 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90612667 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.88339160 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88274908 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87944311 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87878254 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86937652 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84845094 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84209667 |
| 68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83573478 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83484897 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81389841 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78757701 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78204727 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78079734 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.73258621 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72759100 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72494627 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71528319 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69295626 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67976843 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67111956 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66696799 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.64649636 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63346963 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62409053 |
| 85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62097549 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61525693 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60933587 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60617470 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59961129 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59649696 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.58667243 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57973763 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57612727 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56495402 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56469083 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53568530 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52469764 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.51786232 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51662122 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51477005 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50466832 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49833470 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.49725413 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49529885 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.49450930 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49161918 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48419455 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47722839 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45886646 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45249968 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45169849 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45150245 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43871673 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43262324 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42645758 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42528911 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42414280 |
| 118 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41801073 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41720062 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41416194 |
| 121 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41294812 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39425100 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39259016 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37714945 |
| 125 | Focal adhesion_Homo sapiens_hsa04510 | 0.37099193 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36256706 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.34702213 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33081885 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31223013 |
| 130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30877698 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30136778 |
| 132 | Phototransduction_Homo sapiens_hsa04744 | 0.29938084 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26381228 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25507426 |

